GE Capital HFS Provides $320MM Facility to Diplomat Pharmacy



GE Capital, Healthcare Financial Services (HFS) announced it provided a $320 million senior secured credit facility to Diplomat Pharmacy. GE Capital Markets was lead arranger and bookrunner on the transaction.

A portion of the funds was used to acquire BioRx, a Cincinnati, OH-based highly specialized pharmacy and infusion services company that provides treatments for patients with ultra-orphan and rare, chronic diseases. The remainder of the funds will be available for working capital and other general corporate purposes.

“We’re pleased to have successfully completed this latest financing for Diplomat,” said David Varhol, managing director of GE Capital, Healthcare Financial Services’ corporate finance team. “We’re seeing continued rapid growth and consolidation within the specialty pharmacy industry, particularly in the specialty infusion space. This acquisition helps expand Diplomat’s presence in specialty infusion while it continues its rapid organic growth.”


Like this story? Begin each business day with news you need to know! Click here to register now for our FREE Daily E-News Broadcast and start YOUR day informed!

Leave a comment

View Latest Digital Edition

Terry Mulreany
Subscriptions: 800 708 9373 x130
[email protected]
Susie Angelucci
Advertising: 484.459.3016
[email protected]

View Latest Digital Edition

Visit our sister website for news, information, exclusive articles,
deal tables and more on the asset-based lending, factoring,
and restructuring industries.
www.abfjournal.com